(Q42167771)

17 October 2017

title

Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial (English)

1 reference

17 October 2017

1 reference

1 reference

5

Michael Wolzt

1 reference

17 October 2017

2

Bernd Jilma

1 reference

17 October 2017

Ghazaleh Gouya

1

1 reference

17 October 2017

Marianne Niel

series ordinal

3

1 reference

17 October 2017

Beate Eichelberger

series ordinal

4

1 reference

17 October 2017

Simon Panzer

series ordinal

6

1 reference

17 October 2017

publication date

1 May 2009

1 reference

17 October 2017

1 reference

17 October 2017

volume

20

1 reference

17 October 2017

issue

3

1 reference

17 October 2017

page(s)

171-176

1 reference

Ischemic stroke prevention: an update on antiplatelet therapy

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Aggregometry detects platelet hyperreactivity in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Aspirin resistance: what, why and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Platelet function predicts myocardial damage in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

A new point-of-care method for monitoring anti-platelet therapy: application of the cone and plate(let) analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Impact--the cone and plate(let) analyzer: testing platelet function and anti-platelet drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

Aspirin resistance and adverse clinical events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

The formation of platelet-leukocyte aggregates varies during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100902745117

10.1080/09537100902745117

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference